MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,013 | -94.0% | 3,753 | -91.9% | 0.00% | – |
| Q3 2022 | $17,000 | +1600.0% | 46,593 | +1202.2% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 3,578 | -39.5% | 0.00% | – |
| Q1 2022 | $3,000 | -70.0% | 5,911 | -45.0% | 0.00% | – |
| Q4 2021 | $10,000 | -60.0% | 10,750 | +23.1% | 0.00% | – |
| Q2 2021 | $25,000 | -35.9% | 8,734 | -49.2% | 0.00% | – |
| Q1 2021 | $39,000 | +225.0% | 17,204 | +105.1% | 0.00% | – |
| Q4 2020 | $12,000 | +71.4% | 8,387 | +86.8% | 0.00% | – |
| Q3 2020 | $7,000 | -69.6% | 4,491 | -59.2% | 0.00% | – |
| Q2 2020 | $23,000 | -23.3% | 10,995 | -30.3% | 0.00% | – |
| Q1 2020 | $30,000 | -74.4% | 15,780 | -61.1% | 0.00% | – |
| Q4 2019 | $117,000 | -1.7% | 40,538 | +73.7% | 0.00% | – |
| Q3 2019 | $119,000 | -42.8% | 23,342 | -11.0% | 0.00% | – |
| Q2 2019 | $208,000 | +76.3% | 26,227 | +47.0% | 0.00% | – |
| Q1 2019 | $118,000 | +2260.0% | 17,847 | +2004.6% | 0.00% | – |
| Q4 2018 | $5,000 | – | 848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |